Free Trial
NYSE:BME

BlackRock Health Sciences Trust (BME) Stock Price, News & Analysis

$41.15
0.00 (0.00%)
(As of 07/26/2024 ET)
Today's Range
$41.11
$41.52
50-Day Range
$39.38
$41.88
52-Week Range
$35.53
$42.86
Volume
30,316 shs
Average Volume
33,299 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
6.20%
Price Target
N/A
BME stock logo

About BlackRock Health Sciences Trust Stock (NYSE:BME)

BlackRock Health Sciences Trust is a closed-ended equity mutual fund launched by BlackRock, Inc. The fund is managed by BlackRock Advisors, LLC. It invests in the public equity markets of the United States. The fund seeks to invest in stocks of companies operating in the health sciences and related sectors, which include businesses involved in researching, developing, producing, distributing or delivering medical, dental, optical, pharmaceutical or biotechnology products, supplies, equipment, or services. It also invests through equity derivatives, with an emphasis on option writing. The fund benchmarks the performance of its portfolio against the Russell 3000 Healthcare Index. BlackRock Health Sciences Trust was formed on March 31, 2005 and is domiciled in the United States.

BME Stock Price History

BME Stock News Headlines

BlackRock Health Sciences Trust (BME)
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
BME: Historically One Of The Best Times For Entry
Blackrock Health Sciences Trust's Dividend Analysis
BME - BlackRock Health Sciences Trust
Blackrock Health Sciences Trust (NYSE: BME)
See More Headlines
Receive BME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BlackRock Health Sciences Trust and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 6/28 Dividend
6/14/2024
Dividend Payable
6/28/2024
Ex-Dividend for 7/31 Dividend
7/15/2024
Today
7/26/2024
Dividend Payable
7/31/2024

Industry, Sector and Symbol

Industry
Asset Management
Sub-Industry
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$20.41 million

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

BME Stock Analysis - Frequently Asked Questions

How have BME shares performed this year?

BlackRock Health Sciences Trust's stock was trading at $40.46 on January 1st, 2024. Since then, BME shares have increased by 1.7% and is now trading at $41.15.
View the best growth stocks for 2024 here
.

What is Javier Hernani Burzako's approval rating as BlackRock Health Sciences Trust's CEO?

3 employees have rated BlackRock Health Sciences Trust Chief Executive Officer Javier Hernani Burzako on Glassdoor.com. Javier Hernani Burzako has an approval rating of 100% among the company's employees. This puts Javier Hernani Burzako in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are BlackRock Health Sciences Trust's major shareholders?

Top institutional investors of BlackRock Health Sciences Trust include Nova R Wealth Inc., Cambridge Investment Research Advisors Inc., Raymond James & Associates and NBC Securities Inc..
View institutional ownership trends
.

How do I buy shares of BlackRock Health Sciences Trust?

Shares of BME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of BlackRock Health Sciences Trust own?

Based on aggregate information from My MarketBeat watchlists, some other companies that BlackRock Health Sciences Trust investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), AT&T (T), Gilead Sciences (GILD), International Business Machines (IBM), Johnson & Johnson (JNJ) and Verizon Communications (VZ).

This page (NYSE:BME) was last updated on 7/27/2024 by MarketBeat.com Staff

From Our Partners